The announcement calls for multidisciplinary proposals. Are R03 planning grant applications containing a mixture of heart, lung, and blood projects favored?
The Progenitor Cell Biology Consortium will bring together cardiovascular, pulmonary and hematopoietic researchers, along with progenitor cell biologists, immunologists and other related fields. However, while each R03 application should be multidisciplinary and synergistic, applications containing a mix of heart, lung and blood applications will NOT be given priority over other combinations of disciplines.
Related Questions
- How closely will the projects and cores implemented during the first year planning year correlate with the proposals in the applications?
- What are the differences among a Program Announcement, a Request for Applications, and a Request for Proposals?
- Whats the difference between a request for applications (RFA) and a program announcement (PA)?